HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Beyond increased risk: Obesity hinders cancer diagnosis, treatment
-
- Ganetespib showed activity in KRAS-mutant NSCLC
- Poor less likely to receive guideline-conforming care for breast cancer
- Prognostic factors for retroperitoneal sarcoma diminish after 1 year
- PSA screening failed to provide mortality benefit
- Sorafenib improved progression, no effect on survival in lung cancer
- Treatment of multiple myeloma in a Jehovah’s Witness Amit Mehta, MD
- ASH 2011: Clinically relevant highlights regarding venous thromboembolism and anticoagulation Stephan Moll, MD
- FDA approves glucarpidase to treat patients with toxic methotrexate levels
-
- A 45-year-old male with small cell lung cancer, superior vena cava syndrome Munir Ghesani, MD, FACNM; Sam Altman, MD; Zheng Ma, MD; Rangaswamy Chintapatla, MD; Anupama Goel, MD
- Extra-intestinal location for primary non-metastatic GIST associated with increased risk for death
- IP cisplatin, early start of chemotherapy associated with improved efficacy of iceMFP chemotherapy
- Resources available to help health care professionals provide palliative care to children Christine A. Zawistowski, MD